EGFR突变晚期NSCLC患者第三代EGFR-TKI治疗进展后不同治疗模式疗效的真实世界研究
杨俊玲, 张桂芳, 慕竹青, 黄普超, 马晓艳, 梁嘉欣
Efficacy of different treatment modalities in the real-world setting for advanced EGFR-mutant NSCLC patients after progression on third-generation EGFR-TKI treatment
Yang Junling, Zhang Guifang, Mu Zhuqing, Huang Puchao, Ma Xiaoyan, Liang Jiaxin
国际肿瘤学杂志
.
2026, (4): 201
-206
.
DOI: 10.3760/cma.j.cn371439-20251015-00033
